General Information of the m6A Target Gene (ID: M6ATAR00285)
Target Name DNA-binding protein inhibitor ID-2 (ID2)
Synonyms
Class B basic helix-loop-helix protein 26; bHLHb26; Inhibitor of DNA binding 2; Inhibitor of differentiation 2; BHLHB26
    Click to Show/Hide
Gene Name ID2
Chromosomal Location 2p25.1
Function
Transcriptional regulator (lacking a basic DNA binding domain) which negatively regulates the basic helix-loop-helix (bHLH) transcription factors by forming heterodimers and inhibiting their DNA binding and transcriptional activity. Implicated in regulating a variety of cellular processes, including cellular growth, senescence, differentiation, apoptosis, angiogenesis, and neoplastic transformation. Inhibits skeletal muscle and cardiac myocyte differentiation. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Restricts the CLOCK and ARNTL/BMAL1 localization to the cytoplasm. Plays a role in both the input and output pathways of the circadian clock: in the input component, is involved in modulating the magnitude of photic entrainment and in the output component, contributes to the regulation of a variety of liver clock-controlled genes involved in lipid metabolism.
    Click to Show/Hide
Gene ID 3398
Uniprot ID
ID2_HUMAN
HGNC ID
HGNC:5361
Ensembl Gene ID
ENSG00000115738
KEGG ID
hsa:3398
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ID2 can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Protein virilizer homolog (VIRMA) [WRITER]
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary KIAA1429 facilitated migration and invasion of Hepatocellular carcinoma cells by inhibiting DNA-binding protein inhibitor ID-2 (ID2) via upregulating m6A modification of ID2 mRNA.
Target Regulation Up regulation
Responsed Disease Hepatocellular carcinoma ICD-11: 2C12.02
Pathway Response RNA degradation hsa03018
Cell Process Cell migration and invasion
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hep-G2/2.2.15 Hepatoblastoma Homo sapiens CVCL_L855
L-02 Endocervical adenocarcinoma Homo sapiens CVCL_6926
Huh-7 Adult hepatocellular carcinoma Homo sapiens CVCL_0336
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary KIAA1429 facilitated migration and invasion of Hepatocellular carcinoma cells by inhibiting DNA-binding protein inhibitor ID-2 (ID2) via upregulating m6A modification of ID2 mRNA.
Responsed Disease Hepatocellular carcinoma [ICD-11: 2C12.02]
Target Regulator Protein virilizer homolog (VIRMA) WRITER
Target Regulation Up regulation
Pathway Response RNA degradation hsa03018
Cell Process Cell migration and invasion
In-vitro Model Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
Hep-G2/2.2.15 Hepatoblastoma Homo sapiens CVCL_L855
L-02 Endocervical adenocarcinoma Homo sapiens CVCL_6926
Huh-7 Adult hepatocellular carcinoma Homo sapiens CVCL_0336
References
Ref 1 KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA. Onco Targets Ther. 2019 May 7;12:3421-3428. doi: 10.2147/OTT.S180954. eCollection 2019.